Primary Health Properties — Internal and external momentum

Primary Health Properties (LSE: PHP)

Last close As at 17/03/2026

GBP1.01

−0.30 (−0.30%)

Market capitalisation

GBP2,624m

More on this equity

Research: Real Estate

Primary Health Properties — Internal and external momentum

Primary Health Properties (PHP) has reported 2025 results in line with market expectations, with adjusted EPS of 7.3p comfortably covering DPS of 7.1p (+3%). The company has entered 2026 with strong momentum in both organic rental income and the integration of Assura, and management targets a 2026 fully covered DPS of 7.3p (the 30th consecutive year of growth). 83% of the expected £9m cost synergies have been put in place and plans are well advanced to reduce leverage back to within the targeted range ahead of previous expectations, including an expansion of its primary care joint venture (JV) and establishing a new strategic JV for the private hospital portfolio.

Martyn King

Written by

Martyn King

Director, Financials. Property and Insurance

Real estate

2025 annual results

18 March 2026

Price 101.10p
Market cap £2,624m

Shares in issue

2,595.1m
Code PHP
Primary exchange LSE
Secondary exchange JSE
Price Performance

Business description

Primary Health Properties is a long-term investor in primary healthcare property in the UK and the Republic of Ireland. Assets are mainly let on long leases to GPs and the NHS or HSE, organisations backed by the UK and Irish governments, respectively. The tenant profile and long average lease duration provide an exceptionally secure rental income stream.

Analyst

Martyn King
+44 (0)20 3077 5700

Primary Health Properties is a research client of Edison Investment Research Limited

Notes: Earnings and EPS are shown on PHP’s adjusted basis, which is EPRA earnings excluding the amortisation of mark-to-market adjustments for fixed-rate debt acquired. NAV per share is on an EPRA NTA basis, having previously been shown on an adjusted EPRA NTA basis.

Year end Net rental income (£m) Earnings (£m) EPS (£) NAV/share (£) DPS (p) P/NAV (x) Yield (%)
12/24 153.6 92.9 6.95 1.03 6.90 0.98 6.8
12/25 230.0 131.0 7.30 0.99 7.10 1.02 7.0
12/26e 322.9 192.2 7.40 1.02 7.30 0.99 7.2
12/27e 306.9 197.4 7.61 1.05 7.50 0.96 7.4

2025 was transformational for PHP, with the acquisition of Assura offering significant financial and strategic benefits. It created a c £6bn portfolio of long-leased, sustainable healthcare infrastructure assets. These are principally let to government tenants and leading UK healthcare providers, underpinned by demographic trends and supported by government policy. Since then, PHP has made impressive progress with integration and realisation of cost synergies, which will solidly underpin 2026 earnings.

The £1.6bn consideration for Assura included £0.4bn in cash and a key focus is returning the immediate post-transaction loan-to-value (LTV) ratio from 57% at end-2025 to PHP’s medium-term 40–50% target. Good progress has been made with the transfer of further assets to the existing primary care JV with USS and a new private hospital JV, likely to release c £700m of cash, substantially meeting the LTV target. Both are expected to complete around mid-2026. For its £700m private hospital portfolio, PHP has received offers from four credible counterparties and is considering which provides the best balance between delivery and the potential for further growth in what is an attractive healthcare property segment. PHP enjoys significant liquidity headroom, with cash and collateralised undrawn loan facilities of more than £0.6bn after capital commitments.

Organic rental growth continues to increase, adding c £9m or c 3% to the annualised rent roll, which reached £342m. The continued acceleration of open market rent reviews (60% of the rent roll) is particularly encouraging. New asset management and development projects are starting to see rents being rebased upwards, making them economically viable while providing crucial evidence for future rent review settlements across the wider portfolio.

With valuation yields stabilising, rental growth is also generating capital growth. EPRA NTA of 99p/share was 4p lower than at end-2024 but increased 2p on a pro forma basis, excluding the expected acquisition effects. We will review the financial report in detail (which now includes Assura) but expect no change to our EPS, DPS or EPRA NTA forecasts despite changes to the earnings composition.

General disclaimer and copyright

This report has been commissioned by Primary Health Properties and prepared and issued by Edison, in consideration of a fee payable by Primary Health Properties. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2026 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on Primary Health Properties

View All

Latest from the Real Estate sector

View All Real Estate content

Research: TMT

PCI-PAL — Telecom strategic reseller partnership

PCI Pal has signed a major telecom company as a strategic reseller. Expanding the channel partner ecosystem is a key strategic goal for the company, and following on from the February announcement of the signing of a different strategic reseller partnership, this provides further support to the company’s ambitious medium-term growth targets.

Continue Reading